Peptide purity is often shown as a percentage, but that number only tells part of the story. When a peptide sample is analysed, the main compound may be present alongside smaller amounts of other materials. These are generally described as impurities.
For laboratory researchers, understanding where these impurities can come from—and how analytical testing detects them—provides useful context when reviewing a batch.
Where Do Peptide Impurities Come From?
Peptides can be produced synthetically through a series of controlled chemical steps. Even with careful management, the process can leave or create small traces of unwanted material.
Depending on the peptide and the manufacturing process, they may be incomplete peptide sequences, by-products of synthesis, residual starting materials or compounds formed during degradation.
The storage and handling of a material over time can also influence its quality. Some peptides are sensitive to moisture, heat, light, or storage conditions and can be chemically changed.
The analytical results should therefore not be used in isolation but in conjunction with the batch information and storage documentation.
How Do You Test For Impurities?
Peptide purity is often determined by high-performance liquid chromatography (HPLC).
In HPLC, the components of the sample are separated and can be observed as peaks on a chromatogram. The main peak is usually attributed to the material of interest, whereas the other peaks may correspond to other constituents in the sample.
HPLC purity percentage is the relative percentage of the main chromatographic peak under the conditions of that particular analysis.
It is important to understand what this figure does not show. A high HPLC percentage does not, by itself, establish the identity of the main compound. Identity and purity answer different analytical questions.
For this reason, techniques such as mass spectrometry may also be used to provide information about molecular identity.
Why Batch-Specific Results Matter
Peptide quality should not be assumed to remain identical from one production batch to another.
Changes in synthesis, purification, processing, transport or storage can influence the analytical profile of a material. Testing an actual batch therefore provides more useful information than relying on a general specification that applies to a product catalogue.
A batch-specific Certificate of Analysis can help researchers review the reported purity result, analytical method, batch reference and other available test information.
Looking Beyond a Single Percentage
A purity figure is useful, but it should be read in context.
Researchers may also want to consider whether the compound identity has been checked, whether the test relates to the supplied batch, which analytical method was used and whether supporting documentation can be traced back to that batch.
At Verified Peptides Australia, our approach is centred on analytical documentation and batch traceability so researchers can review the available information rather than relying on a purity claim alone.
Research materials supplied by Verified Peptides are intended for laboratory research purposes only and are not for human or veterinary use.